Education
About Us
Working with TipRanks
Follow Us
Cerus Corp (CERS)
NASDAQ:CERS
Earnings Data
Report Date
Oct 30, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.03Last Year’s EPS
-0.02Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive outlook with significant revenue growth, strong IFC sales, and successful international expansion, despite challenges in the China market and increased operating expenses.Company Guidance
Record Product Revenue
Cerus Corporation reported a product revenue of $52.4 million for Q2 2025, marking a 16% year-over-year increase. The company has raised its full-year 2025 product revenue guidance to a range of $200 million to $203 million from the previous $194 million to $200 million.
Strong Growth in INTERCEPT Fibrinogen Complex (IFC) Sales
IFC product revenue for Q2 was $5.6 million, significantly up from $2 million in the prior year period. Full-year 2025 IFC sales are now expected to be between $16 million and $18 million, up from the previous guidance of $12 million to $15 million.
Positive Non-GAAP Adjusted EBITDA
Cerus Corporation achieved its fifth consecutive quarter of positive non-GAAP adjusted EBITDA, totaling $935,000 for Q2 2025.
Expansion and Innovations in Product Offerings
The INT200 Illuminator received CE Mark approval and was launched, enhancing operations in blood centers across approximately 40 countries.
Successful Launch and Adoption in International Markets
Canadian Blood Services transitioned to 100% routine use of INTERCEPT platelets, and there was significant growth in the Middle East with Saudi Arabia, Kuwait, and UAE leading platelet growth.
CERS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CERS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 05, 2025 | $1.28 | $1.29 | +0.78% |
May 01, 2025 | $1.30 | $1.35 | +3.85% |
Feb 20, 2025 | $1.74 | $1.65 | -5.17% |
Oct 30, 2024 | $1.72 | $1.57 | -8.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cerus Corp (CERS) report earnings?
Cerus Corp (CERS) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
What is Cerus Corp (CERS) earnings time?
Cerus Corp (CERS) earnings time is at Oct 30, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CERS EPS forecast?
CERS EPS forecast for the fiscal quarter 2025 (Q3) is -0.03.